skip to content

Cambridge Biosciences DTP PhD Programme

 
Kyle Reid-Frontiers in Immunology

Congratulations to Kyle Reid, 2019 cohort PhD student on the BBSRC DTP programme, for publishing the Research Article ‘Brain Cells Release Calreticulin That Attracts and Activates Microglia, and Inhibits Amyloid Beta Aggregation and Neurotoxicity’ in Frontiers in Immunology.

 

Here, Kyle and colleagues show that the protein calreticulin is released by microglia and neurons in the brain, and acts: as an alarmin to recruit and activate microglia, as an extracellular chaperone to prevent Aβ aggregation, and as a neuroprotectant against Aβ neurotoxicity.

 

Abstract:

Calreticulin is a chaperone, normally found in the endoplasmic reticulum, but can be released by macrophages into the extracellular medium. It is also found in cerebrospinal fluid bound to amyloid beta (Aβ). We investigated whether brain cells release calreticulin, and whether extracellular calreticulin had any effects on microglia and neurons relevant to neuroinflammation and neurodegeneration. We found that microglia release nanomolar levels of calreticulin when inflammatory-activated with lipopolysaccharide, when endoplasmic reticulum stress was induced by tunicamycin, or when cell death was induced by staurosporine, and that neurons release calreticulin when crushed. Addition of nanomolar levels of extracellular calreticulin was found to chemoattract microglia, and activate microglia to release cytokines TNF-α, IL-6 and IL-1β, as well as chemokine (C-C motif) ligand 2. Calreticulin blocked Aβ fibrillization and modified Aβ oligomerization, as measured by thioflavin T fluorescence and transmission electron microscopy. Extracellular calreticulin also altered microglial morphology and proliferation, and prevented Aβ-induced neuronal loss in primary neuron-glial cultures. Thus, calreticulin is released by microglia and neurons, and acts: as an alarmin to recruit and activate microglia, as an extracellular chaperone to prevent Aβ aggregation, and as a neuroprotectant against Aβ neurotoxicity.

To read the full publication, please click here
Reid, K.M. et al. (2022). Brain Cells Release Calreticulin That Attracts and Activates Microglia, and Inhibits Amyloid Beta Aggregation and Neurotoxicity. Front Immunol., 13 (859686): pp. 1-12.

Latest news

Celebrating Student Research at the Cambridge Biosciences DTP Symposium 2025

25 July 2025

On Tuesday 22 July, the Cambridge Biosciences Doctoral Training Partnership (DTP) held its Annual Student Symposium at Robinson College. The event celebrated the great research students are doing and helped bring people in the Cambridge Biosciences community closer together.

PIPS Symposium 2025: Connecting Students with Future Opportunities

1 April 2025

Our annual PIPS Symposium took place on Friday, 28 March, at the Babraham Campus, bringing together students and host organisations for a half-day of networking, insights, and career development opportunities. The event is designed to support current students who have yet to complete their PIPS by connecting them with potential host organisations across various sectors.

Cambridge Researchers Identify Genes Linked to Obesity in Both Dogs and Humans

17 March 2025

Dr. Natalie Wallis and Dr. Alyce McClellan, both alumnae of the Cambridge Biosciences DTP programme (2019 cohort), are joint first authors on a groundbreaking study published in Science.